The Vitiligo Treatment Market is predicted to reach US$ by 2030 from US$ 1.42 billion in 2021, and to grow at a CAGR of 6.14 % between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
By Treatment (Topical Treatment, Surgical Procedures, Light Therapy), by Disease Type (Segmental Vitiligo, Nonsegmental Vitiligo), by End User (Hospitals, Aesthetic Clinics
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Incyte Corporation, Astellas Pharma Inc., Baxter International Inc., Dr. Reddy's Laboratories Ltd., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries, GlaxoSmithKline Plc, F. Hoffman La Roche AG, Eli Lilly and Company, Bausch Health Companies Inc., STRATA Skin Sciences, Dermavant Sciences, Inc., Aclaris Therapeutics Inc., Bristol - Myers Squibb, among others
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Vitiligo Treatment - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Vitiligo Treatment - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Vitiligo Treatment - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Vitiligo Treatment - ANALYSIS & FORECAST, BY REGION
North America Vitiligo Treatment
1. North America Vitiligo Treatment , by Country
1. US
2. Canada
1. North America Vitiligo Treatment , by Product
2. North America Vitiligo Treatment , by Type
3. North America Vitiligo Treatment , by Gender
4. North America Vitiligo Treatment , by Sales Channel
3. Europe Vitiligo Treatment
1. Europe Vitiligo Treatment , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Vitiligo Treatment , by Product
3. Europe Vitiligo Treatment , by Type
4. Europe Vitiligo Treatment , by Gender
5. Europe Vitiligo Treatment , by Sales Channel
4. Asia Pacific Vitiligo Treatment
1. Asia Pacific Vitiligo Treatment , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Vitiligo Treatment , by product
3. Asia Pacific Vitiligo Treatment , by Type
4. Asia Pacific Vitiligo Treatment , by Gender
5. Asia Pacific Vitiligo Treatment , by Sales Channel
5. Rest of the World Vitiligo Treatment
1. Rest of the World Vitiligo Treatment , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Vitiligo Treatment , by Product
3. Rest of the World Vitiligo Treatment , by Type
4. Rest of the World Vitiligo Treatment , by Gender
5. Rest of the World Vitiligo Treatment , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 57